Clik here to view.
AVITA Medical and the Gates Center for Regenerative Medicine at the...
VALENCIA, Calif., MELBOURNE, Australia & AURORA, Colo. AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical...
View ArticleClik here to view.
マシモ・ペイシェント・セーフティーネットとrainbowアコースティックモニタリングを使用して術後患者で酸素飽和度低下と緩徐呼吸の発生頻度を究明する研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Journal of Clinical Monitoring and...
View ArticleClik here to view.
GN CORPORATION: Vision Restored with Corneal Cell Transplant Using a Nano...
TOKYO A novel cell transplantation method to treat corneal endothelial diseases such as bullous keratopathy using a nano-composite gel sheet developed by Japanese scientists was granted Indian...
View ArticleClik here to view.
Delta-Fly Pharma, Inc. Initiated Phase 3 Clinical Study of DFP-10917 and...
TOKUSHIMA, Japan Delta-Fly Pharma, Inc. (TOKYO: 4598) announces that patients have registered for clinical studies in the USA on anti-cancer drug candidates DFP-10917 and DFP-14927. DFP-10917 is an...
View ArticleClik here to view.
武田呈报的ALK+ NSCLC长期数据显示，ALUNBRIG® (brigatinib)在2年随访期之后继续展示一线治疗中的优效性
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(TSE:4502/NYSE:TAK)今天发布了3期ALTA-1L试验的更新数据，该试验评估ALUNBRIG...
View ArticleClik here to view.
EOS imaging Announces the Upcoming Launch of EOSedge™, Its New Generation...
PARIS Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005639/en/ (Photo: Business Wire) EOS imaging (Paris:EOSI)...
View ArticleClik here to view.
GN CORPORATION：采用纳米薄片技术进行的角膜细胞移植可恢复视力；日本公司在印度获得专利
东京 (美国商业资讯)–日本科学家开发了一种新型细胞移植方法，采用纳米复合胶质薄片治疗角膜内皮疾病，例如大疱性角膜病变，日本GN Corporation (GNC)的这种方法获得了印度专利。该方法早前获得日本专利，其采用遗体供者角膜衍生细胞，若干例患者采用实验室培养角膜内皮前体细胞恢复了视力。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
ジーエヌコーポレーション：ナノシート手法を使用した角膜細胞移植で視力を回復、日本企業がインドで特許を交付される
東京 （ビジネスワイヤ） — 水疱性角膜症などの角膜内皮疾患をナノ複合ゲルシートで治療するための新規細胞移植手法を日本の科学者らが開発し、日本のジーエヌコーポレーション（GNC）にインド特許が交付されました。この手法は既に日本特許として交付されており、1人の死体ドナー角膜に由来する細胞がラボ培養した角膜内皮細胞前駆細胞を使用することで、患者数人の視力を救うことに使用できるものです。...
View ArticleClik here to view.
Genetron Health Obtains Approval for Semiconductor-based NGS System GENETRON S5
BEIJING Genetron Health, a China-based precision oncology company that covers full-cycle cancer care, has obtained regulatory approval in China to launch its GENETRON S5 for clinical use. The...
View ArticleClik here to view.
マクロジェン: 東北アジア最大規模のリファレンスゲノムDBを構築
韓国ソウル （ビジネスワイヤ） — 盆唐(ブンダン)ソウル大学病院、マクロジェン(www.macrogen.com) (KOSDAQ: 038290) 共同研究チームは東北アジア最大規模となる東北アジア人のリファレンスゲノムデータベース(Northeast Asian Reference Database、NARD,...
View ArticleClik here to view.
武田薬品、ALK+ NSCLC のファーストライン治療でALUNBRIG®（ブリガチニブ）が2年間の追跡後も一貫した優位性を示す長期データを発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
Shape Memory Medical Receives PMDA Approval for the IMPEDE® Embolization Plug...
SANTA CLARA, Calif. Shape Memory Medical Inc. announced today that its IMPEDE® Embolization Plugs have been approved in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA). Cosmotec,...
View ArticleClik here to view.
Seattle Genetics and Astellas Announce Clinical Trial Collaboration with...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”), today announced a clinical collaboration...
View ArticleClik here to view.
Macrogen: Successful Construction of the Largest Northeast Asian Reference Panel
SEOUL, South Korea The joint research team from Seoul National University Bundang Hospital and Macrogen (www.macrogen.com) (KOSDAQ: 038290) announced the release of one of the largest Northeast...
View ArticleClik here to view.
Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics
TOKYO & SAN FRANCISCO Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Audentes Therapeutics, Inc. (NASDAQ: BOLD, Chairman and CEO: Matthew R....
View ArticleClik here to view.
Gen ReとPAI Healthが戦略的協力関係を強化
コネチカット州スタンフォード 数十年に渡る証拠により、心肺機能が長寿そして将来の健康の主要な予測因子であることが証明されています。しかし、それは保険顧客の健康プロファイルとしては大部分が見過ごされてきました。世界的な大手再保険会社であるGen Reとヘルステクノロジーソフトウェア会社であるPAI Healthとの間で締結された独占契約が、このような状況に大きな変化をもたらすことになります。...
View ArticleClik here to view.
Co-Diagnostics JV CoSara Receives Indian Regulatory Approval for Five...
SALT LAKE CITY Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced...
View ArticleClik here to view.
Kraig Biocraft Laboratories Completes Hatching Second Generation of Silkworms
ANN ARBOR, Mich. Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announced today that Prodigy Textiles, the Company’s Vietnamese...
View ArticleClik here to view.
Healthcare+ Expo Taiwan 2019 Exhibitor Profiles
TAIPEI, Taiwan Healthcare+ Expo Taiwan runs December 5 – 8, 2019 at the at the Taipei Nangang Exhibition Center in Taipei, Taiwan. Business Wire is an official media partner for Healthcare+ Expo...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Bortezomib for Injection 3.5...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View Article